Literature DB >> 23625013

Extended lymphadenectomy in gastric cancer is crucial.

Lorenzo Ferri1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23625013     DOI： 10.1007/s00268-013-2069-7

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  23 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

3.  Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery.

Authors:  Jun Ho Lee; Keun Won Ryu; Jin-Hee Lee; Sook Ryun Park; Chan Gyoo Kim; Myoung Cheorl Kook; Byung-Ho Nam; Young-Woo Kim; Jae-Moon Bae
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

4.  Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study.

Authors:  M Degiuli; M Sasako; A Ponti; T Soldati; F Danese; F Calvo
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

5.  Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study.

Authors:  Franco Roviello; Simone Rossi; Daniele Marrelli; Corrado Pedrazzani; Giovanni Corso; Carla Vindigni; Paolo Morgagni; Luca Saragoni; Giovanni de Manzoni; Anna Tomezzoli
Journal:  J Surg Oncol       Date:  2006-09-15       Impact factor: 3.454

6.  Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC).

Authors:  S Folli; P Morgagni; F Roviello; G De Manzoni; D Marrelli; L Saragoni; A Di Leo; M Gaudio; O Nanni; A Carli; C Cordiano; D Dell'Amore; A Vio
Journal:  Jpn J Clin Oncol       Date:  2001-10       Impact factor: 3.019

7.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

8.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma.

Authors:  P Edwards; G R J C Blackshaw; W G Lewis; J D Barry; M C Allison; D R B Jones
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

10.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; F Calvo
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640
View more
  4 in total

1.  Gastrectomy with Extended Lymphadenectomy: a North American Perspective.

Authors:  Alexandre Gosselin-Tardif; Jessica Lie; Ioana Nicolau; Juan Carlos Molina; Jonathan Cools-Lartigue; Liane Feldman; Jonathan Spicer; Carmen Mueller; Lorenzo Ferri
Journal:  J Gastrointest Surg       Date:  2017-11-09       Impact factor: 3.452

2.  Current status of management of malignant disease: current management of esophageal cancer.

Authors:  Jonathan Cools-Lartigue; Jonathan Spicer; Lorenzo E Ferri
Journal:  J Gastrointest Surg       Date:  2015-02-04       Impact factor: 3.452

3.  Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis.

Authors:  Pei Wu; Pengliang Wang; Bin Ma; Songcheng Yin; Yuen Tan; Wenbin Hou; Zhenning Wang; Huimian Xu; Zhi Zhu
Journal:  Cancer Manag Res       Date:  2018-10-26       Impact factor: 3.989

4.  Impact of the introduction of formal D2 lymphadenectomy for gastric cancer in a Western setting.

Authors:  Alexandre Brind'Amour; Jean-Pierre Gagné; Jean-Charles Hogue; Éric Poirier
Journal:  Can J Surg       Date:  2021-03-02       Impact factor: 2.089
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.